219 related articles for article (PubMed ID: 38046361)
1. (Poly)phenolic compounds and gut microbiome: new opportunities for personalized nutrition.
Narduzzi L; Agulló V; Favari C; Tosi N; Mignogna C; Crozier A; Rio DD; Mena P
Microbiome Res Rep; 2022; 1(3):16. PubMed ID: 38046361
[TBL] [Abstract][Full Text] [Related]
2. Unravelling phenolic metabotypes in the frame of the COMBAT study, a randomized, controlled trial with cranberry supplementation.
Tosi N; Favari C; Bresciani L; Flanagan E; Hornberger M; Narbad A; Del Rio D; Vauzour D; Mena P
Food Res Int; 2023 Oct; 172():113187. PubMed ID: 37689939
[TBL] [Abstract][Full Text] [Related]
3. (Poly)phenol-related gut metabotypes and human health: an update.
Hu J; Mesnage R; Tuohy K; Heiss C; Rodriguez-Mateos A
Food Funct; 2024 Mar; 15(6):2814-2835. PubMed ID: 38414364
[TBL] [Abstract][Full Text] [Related]
4. Perspective: Metabotyping-A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease.
Palmnäs M; Brunius C; Shi L; Rostgaard-Hansen A; Torres NE; González-Domínguez R; Zamora-Ros R; Ye YL; Halkjær J; Tjønneland A; Riccardi G; Giacco R; Costabile G; Vetrani C; Nielsen J; Andres-Lacueva C; Landberg R
Adv Nutr; 2020 May; 11(3):524-532. PubMed ID: 31782487
[TBL] [Abstract][Full Text] [Related]
5. Main drivers of (poly)phenol effects on human health: metabolite production and/or gut microbiota-associated metabotypes?
Iglesias-Aguirre CE; Cortés-Martín A; Ávila-Gálvez MÁ; Giménez-Bastida JA; Selma MV; González-Sarrías A; Espín JC
Food Funct; 2021 Nov; 12(21):10324-10355. PubMed ID: 34558584
[TBL] [Abstract][Full Text] [Related]
6. Where to Look into the Puzzle of Polyphenols and Health? The Postbiotics and Gut Microbiota Associated with Human Metabotypes.
Cortés-Martín A; Selma MV; Tomás-Barberán FA; González-Sarrías A; Espín JC
Mol Nutr Food Res; 2020 May; 64(9):e1900952. PubMed ID: 32196920
[TBL] [Abstract][Full Text] [Related]
7. Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies.
Favari C; Rinaldi de Alvarenga JF; Sánchez-Martínez L; Tosi N; Mignogna C; Cremonini E; Manach C; Bresciani L; Del Rio D; Mena P
Redox Biol; 2024 May; 71():103095. PubMed ID: 38428187
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the cardiometabolic response to (poly)phenols and phytosterols: a review of the COST Action POSITIVe activities.
Gibney ER; Milenkovic D; Combet E; Ruskovska T; Greyling A; González-Sarrías A; de Roos B; Tomás-Barberán F; Morand C; Rodriguez-Mateos A
Eur J Nutr; 2019 Nov; 58(Suppl 2):37-47. PubMed ID: 31492975
[TBL] [Abstract][Full Text] [Related]
9. Plant-Derived (Poly)phenols and Their Metabolic Outcomes: The Pursuit of a Role for the Gut Microbiota.
Freitas PL; Miranda JPN; França LM; Paes AMA
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079768
[TBL] [Abstract][Full Text] [Related]
10. Functional Deficits in Gut Microbiome of Young and Middle-Aged Adults with Prediabetes Apparent in Metabolizing Bioactive (Poly)phenols.
Zhang X; Zhao A; Sandhu AK; Edirisinghe I; Burton-Freeman BM
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33238618
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota: A key factor in the therapeutic effects of (poly)phenols.
Espín JC; González-Sarrías A; Tomás-Barberán FA
Biochem Pharmacol; 2017 Sep; 139():82-93. PubMed ID: 28483461
[TBL] [Abstract][Full Text] [Related]
12. Dietary (poly)phenols and cardiometabolic health: from antioxidants to modulators of the gut microbiota.
Rodriguez-Mateos A; Le Sayec M; Cheok A
Proc Nutr Soc; 2024 Feb; ():1-11. PubMed ID: 38316606
[TBL] [Abstract][Full Text] [Related]
13. Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further.
Rodríguez-Daza MC; Pulido-Mateos EC; Lupien-Meilleur J; Guyonnet D; Desjardins Y; Roy D
Front Nutr; 2021; 8():689456. PubMed ID: 34268328
[TBL] [Abstract][Full Text] [Related]
14. Urolithin Metabotypes can Anticipate the Different Restoration of the Gut Microbiota and Anthropometric Profiles during the First Year Postpartum.
Cortés-Martín A; Romo-Vaquero M; García-Mantrana I; Rodríguez-Varela A; Collado MC; Espín JC; Selma MV
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484413
[TBL] [Abstract][Full Text] [Related]
15. Metabotypes of flavan-3-ol colonic metabolites after cranberry intake: elucidation and statistical approaches.
Mena P; Favari C; Acharjee A; Chernbumroong S; Bresciani L; Curti C; Brighenti F; Heiss C; Rodriguez-Mateos A; Del Rio D
Eur J Nutr; 2022 Apr; 61(3):1299-1317. PubMed ID: 34750642
[TBL] [Abstract][Full Text] [Related]
16. Unveiling metabotype clustering in resveratrol, daidzein, and ellagic acid metabolism: Prevalence, associated gut microbiomes, and their distinctive microbial networks.
Eduardo Iglesias-Aguirre C; Romo-Vaquero M; Victoria Selma M; Carlos Espín J
Food Res Int; 2023 Nov; 173(Pt 2):113470. PubMed ID: 37803793
[TBL] [Abstract][Full Text] [Related]
17. The effects of Aronia berry (poly)phenol supplementation on arterial function and the gut microbiome in middle aged men and women: Results from a randomized controlled trial.
Le Sayec M; Xu Y; Laiola M; Gallego FA; Katsikioti D; Durbidge C; Kivisild U; Armes S; Lecomte M; Fança-Berthon P; Fromentin E; Plaza Oñate F; Cruickshank JK; Rodriguez-Mateos A
Clin Nutr; 2022 Nov; 41(11):2549-2561. PubMed ID: 36228567
[TBL] [Abstract][Full Text] [Related]
18. Metabotyping and its role in nutrition research.
Hillesheim E; Brennan L
Nutr Res Rev; 2020 Jun; 33(1):33-42. PubMed ID: 31434587
[TBL] [Abstract][Full Text] [Related]
19. Metabotyping and its application in targeted nutrition: an overview.
Riedl A; Gieger C; Hauner H; Daniel H; Linseisen J
Br J Nutr; 2017 Jun; 117(12):1631-1644. PubMed ID: 28720150
[TBL] [Abstract][Full Text] [Related]
20. Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes.
Rundblad A; Christensen JJ; Hustad KS; Bastani NE; Ottestad I; Holven KB; Ulven SM
Genes Nutr; 2023 Mar; 18(1):3. PubMed ID: 36899329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
